Free shipping on all orders over $ 500

Safinamide Mesylate

Cat. No. M2006

All AbMole products are for research use only, cannot be used for human consumption.

Safinamide Mesylate Structure
Synonym:

FCE28073, PNU-151774E, NW-1015

Size Price Availability Quantity
5mg USD 40  USD40 In stock
10mg USD 55  USD55 In stock
25mg USD 95  USD95 In stock
50mg USD 130  USD130 In stock
100mg USD 180  USD180 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

Safinamide Mesylate is mesylate salt of Safinamide, which selectively and reversibly inhibits MAO-B with IC50 of 0.45 μM. Safinamide inhibits glutamate release induced by depolarizing conditions in rat hippocampal synaptosomes with IC50 of 9 μM. Safinamide increases neostriatal dopamine concentration. In addition, safinamide is voltage-dependent sodium and calcium channel blocker. Safinamide blocks N and L-type calcium channels and inhibits glutamate and aspartate release from synaptic terminals. Safinamide significantly inhibits cell body degeneration in the substantia nigra pars compacta. Safinamide has a high oral bioavailability (80–92%), is rapidly absorbed in plasma after reaching the peak within 0.5–2 hours declines, with a terminal half-life of about 3, 7, and 13 hours in mice, rats, and monkeys, respectively. Safinamide is currently in a Phase II clinical trial.

Chemical Information
Molecular Weight 398.45
Formula C17H19FN2O2.CH4O3S
CAS Number 202825-46-5
Solubility (25°C) DMSO 80 mg/mL
Water 30 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] Michinori Koebisu, et al. Safinamide Mesilate (Equfina ® TABLETS 50 mg): preclinical and clinical pharmacodynamics, efficacy, and safety

[2] Daniel A Hussar, et al. Safinamide mesylate, Brodalumab, Guselkumab, and Abaloparatide

[3] Thomas Mller. Pharmacokinetic drug evaluation of safinamide mesylate for the treatment of mid-to-late stage Parkinson's disease

[4] Santiago Perez-Lloret, et al. The safety and efficacy of safinamide mesylate for the treatment of Parkinson's disease

Related Monoamine Oxidase Products
Clorgyline

Clorgyline (M&B 9302) is an orally active, blood-brain barrier permeable and selective monoamine oxidase A (MAO-A) inhibitor.

MAO-B-IN-2 

MAO-B-IN-2 is a selective and competitive inhibitor of MAO-B and BChE with IC50 values of 0.51 and 7.00 μM, respectively.

Befloxatone

Befloxatone (MD-370503) is an orally active, selective and reversible inhibitor of Monoamine Oxidase A (MAO-A) (IC50=4 nM).

Moclobemide N-Oxide

Moclobemide N-Oxide (Ro 12-5637) is N-oxide metabolite of Moclobemide.

Indazole

Indazole, also called isoindazole, a heterocyclic aromatic organic compound.

  Catalog
Abmole Inhibitor Catalog




Keywords: Safinamide Mesylate, FCE28073, PNU-151774E, NW-1015 supplier, Monoamine Oxidase, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.